Vitamin D status is associated with skin autofluorescence in patients with type 2 diabetes mellitus: A preliminary report

Cardiovascular Diabetology

Volumn 14, Issue 1, 2015, Pages

  Krul Poel, Y H M ^a   Agca, R ^a   Lips, P ^b   van Wijland, H ^c   Stam, F ^a   Simsek, S ^a,b  

^a Medical Centre Alkmaar   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Department of General Practice   (Netherlands)

Author keywords

Advanced glycation endproducts; Type 2 diabetes mellitus; Vitamin D; Vitamin D deficiency

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; METFORMIN; PLACEBO; SULFONYLUREA; VITAMIN D; 25-HYDROXYVITAMIN D; ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; VITAMIN;

ADULT; ARTICLE; AUTOFLUORESCENCE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE COURSE; EPIDEMIOLOGY; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; LIFESTYLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; NON INVASIVE PROCEDURE; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL; SKIN AUTOFLUORESCENCE; AGED; ANALOGS AND DERIVATIVES; BLOOD; COMBINATION DRUG THERAPY; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FLUORESCENCE IMAGING; METABOLISM; MIDDLE AGED; RISK REDUCTION; SKIN; VITAMIN D DEFICIENCY;

AGED; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPOGLYCEMIC AGENTS; LONGITUDINAL STUDIES; MALE; METFORMIN; MIDDLE AGED; OPTICAL IMAGING; RISK REDUCTION BEHAVIOR; SKIN; SULFONYLUREA COMPOUNDS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84937205801     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-015-0250-z     Document Type: Article

References (39)

1. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
2. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO et al (2007) Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 30:107-112
3. Meerwaldt R, Links T, Zeebregts C, Tio R, Hillebrands JL, Smit A (2008) The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovasc Diabetol 7:29
4. Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN, Lyons TJ et al (2000) Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 275:39027-39031
5. Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321
6. Ramasamy R, Yan SF, Schmidt AM (2012) The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes. Vascul Pharmacol 57:160-167
7. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO et al (2006) Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 29:2654-2659
8. Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J et al (2005) Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes 54:3103-3111
9. Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ et al (2008) Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care 31:517-521
10. Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO et al (2009) Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 52:789-797
11. Noordzij MJ, Mulder DJ, Oomen PH, Brouwer T, Jager J, Castro CM et al (2012) Skin autofluorescence and risk of micro- and macrovascular complications in patients with type 2 diabetes mellitus-a multi-centre study. Diabet Med 29:1556-1561
12. de Vos LC, Mulder DJ, Smit AJ, Dullaart RP, Kleefstra N, Lijfering WM et al (2014) Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease. Arterioscler Thromb Vasc Biol 34:933-938
13. Hofmann B, Adam AC, Jacobs K, Riemer M, Erbs C, Bushnaq H et al (2013) Advanced glycation end product associated skin autofluorescence: a mirror of vascular function? Exp Gerontol 48:38-44
14. de Vos LC, Noordzij MJ, Mulder DJ, Smit AJ, Lutgers HL, Dullaart RP et al (2013) Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease. Arterioscler Thromb Vasc Biol 33:131-138
15. Mitri J, Muraru MD, Pittas AG (2011) Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 65:1005-1015
16. Norman PE, Powell JT (2014) Vitamin D and cardiovascular disease. Circ Res 114:379-393
17. Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017-2029
18. Sciacqua A, Perticone M, Grillo N, Falbo T, Bencardino G, Angotti E et al (2014) Vitamin D and 1-h post-load plasma glucose in hypertensive patients. Cardiovasc Diabetol 13:48
19. Scragg R, Sowers M, Bell C (2004) Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes Care 27:2813-2818
20. Tahrani AA, Ball A, Shepherd L, Rahim A, Jones AF, Bates A (2010) The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. Int J Clin Pract 64:351-355
21. Bellan M, Guzzaloni G, Rinaldi M, Merlotti E, Ferrari C, Tagliaferri A et al (2014) Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. Cardiovasc Diabetol 13:57
22. Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, Squires PE et al (2004) Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89-90:121-125
23. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM et al (2001) Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86:888-894
24. Alvarez JA, Ashraf A (2010) Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010:351385
25. Chagas CE, Borges MC, Martini LA, Rogero MM (2012) Focus on vitamin D, inflammation and type 2 diabetes. Nutrients 4:52-67
26. Ferder M, Inserra F, Manucha W, Ferder L (2013) The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system. Am J Physiol Cell Physiol 304:C1027-C1039
27. Hewison M (2012) An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 76:315-325
28. Zitman-Gal T, Green J, Pasmanik-Chor M, Golan E, Bernheim J, Benchetrit S (2014) Vitamin D manipulates miR-181c, miR-20b and miR-15a in human umbilical vein endothelial cells exposed to a diabetic-like environment. Cardiovasc Diabetol 13:8
29. Salum E, Kals J, Kampus P, Salum T, Zilmer K, Aunapuu M et al (2013) Vitamin D reduces deposition of advanced glycation end-products in the aortic wall and systemic oxidative stress in diabetic rats. Diabetes Res Clin Pract 100:243-249
30. Lee TW, Kao YH, Lee TI, Chang CJ, Lien GS, Chen YJ (2014) Calcitriol modulates receptor for advanced glycation end products (RAGE) in diabetic hearts. Int J Cardiol 173:236-241
31. Krul-Poel YHM, Westra S, ten Boekel E, ter Wee MM, van Schoor NM, van Wijland H et al (2015) Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes (SUNNY Trial): a randomized placebo-controlled trial. Diabetes Care. doi: 10.2337/dc15-0323
32. Krul-Poel YH, Van WH, Stam F, Ten BE, Lips P, Simsek S (2014) Study protocol: a randomised placebo-controlled clinical trial to study the effect of vitamin D supplementation on glycaemic control in type 2 Diabetes Mellitus SUNNY trial. BMC Endocr Disord 14:59
33. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL et al (2004) Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 47:1324-1330
34. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53-58
35. Gerrits EG, Lutgers HL, Kleefstra N, Groenier KH, Smit AJ, Gans RO et al (2008) Skin advanced glycation end product accumulation is poorly reflected by glycemic control in type 2 diabetic patients (ZODIAC-9). J Diabetes Sci Technol 2:572-577
36. Talmor Y, Golan E, Benchetrit S, Bernheim J, Klein O, Green J et al (2008) Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 294:F1059-F1064
37. Miyata T (2002) Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis ("carbonyl stress"). Bull Mem Acad R Med Belg 157:189-196
38. Sturmer M, Sebekova K, Fazeli G, Bahner U, Stab F, Heidland A (2015) 25-Hydroxyvitamin d and advanced glycation endproducts in healthy and hypertensive subjects: are there interactions? J Ren Nutr 25:209-216
39. Koetsier M, Lutgers HL, de Jonge C, Links TP, Smit AJ, Graaff R (2010) Reference values of skin autofluorescence. Diabetes Technol Ther 12:399-403